We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Early Percutaneous Tracheostomy and Swallowing Dysfunction

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01268423
Recruitment Status : Unknown
Verified December 2010 by University of Chile.
Recruitment status was:  Recruiting
First Posted : December 30, 2010
Last Update Posted : January 5, 2011
Information provided by:

December 29, 2010
December 30, 2010
January 5, 2011
January 2011
April 2012   (Final data collection date for primary outcome measure)
Incidence of swallowing dysfunction [ Time Frame: 3 to 5 days after weaning of mechanical ventilation ]
The diagnosis of swallowing dysfunction will be performed by fiberoptic endoscopic evaluation of swallowing (FEES) 3 to 5 days after weaning of mechanical ventilation.
Same as current
Complete list of historical versions of study NCT01268423 on ClinicalTrials.gov Archive Site
  • Ventilator-free days [ Time Frame: 28 days ]
  • Incidence of ventilator-associated pneumonia [ Time Frame: 28 days ]
  • Delirium-free and coma-free days [ Time Frame: 28 days ]
  • Daily dose of sedatives [ Time Frame: 28 days ]
  • ICU-free days [ Time Frame: 28 days ]
  • Critical Care Unit-free days [ Time Frame: 90 days ]
    Length of stay at Critical Care Unit involve days of stay in thre Intensive Care Unit, plus the days of stay in the Intermediate Care Unit.
  • Hospital length of stay [ Time Frame: 90 days ]
  • All cause mortality [ Time Frame: 90 days ]
Same as current
Not Provided
Not Provided
Early Percutaneous Tracheostomy and Swallowing Dysfunction
Impact of Early Percutaneous Tracheostomy on the Incidence of Swallowing Dysfunction in Critically Ill Patients on Mechanical Ventilation. A Randomized Clinical Trial
The aim of the study is to determine if performing an early tracheostomy (within the first 4 days of endotracheal intubation) in critically ill patients on mechanical ventilation, reduces the incidence of swallowing dysfunction.
The development of initial resuscitation maneuvers, associated with a better knowledge of the physiopathology of critical illnesses and the technological development experienced by critical care medicine, allow us to give vital support to patients for long periods of time. In this scenario, a considerable proportion of critically ill patients may require translaryngeal intubation and invasive mechanical ventilation. Patients who require prolonged translaryngeal intubation have a high risk of developing swallowing dysfunction, a condition predisposing to secretions aspiration. Until now, there has been no demonstration of a causal association between the duration of translaryngeal intubation and development of swallowing dysfunction. However, all the studies about this topic have been performed on patients submitted to prolonged translaryngeal intubation. Clinical studies have documented the development of early laryngotracheal lesions after intubation, which might explain post extubation dysfunction of swallowing reflex, probably as consequence of alteration of mechanic and chemo-receptors of the pharyngeal and laryngeal mucosa. There are no studies evaluating the impact of an early percutaneous tracheostomy on the incidence of swallowing dysfunction in critical care patients. The investigators have documented a 38% of swallowing dysfunction in our critically ill patients submitted to prolonged mechanical ventilation. The hypothesis of the study is that performance of an early percutaneous tracheostomy, within the first 4 days of translaryngeal intubation, in critical care patients on mechanical ventilation, reduces the incidence of swallowing dysfunction. The diagnosis of swallowing dysfunction will be performed by fiberoptic endoscopic evaluation of swallowing (FEES) by a trained otolaryngologist, 3 to 5 days after weaning of mechanical ventilation.
Phase 3
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Prevention
Swallowing Disorder
  • Procedure: Percutaneous tracheostomy
    Percutaneous tracheostomy within the first 4 days of mechanical ventilation.
    Other Name: Percutaneous dilatational tracheostomy
  • Procedure: Prolonged translaryngeal intubation
    Prolonged endotracheal intubation, and reevaluation at day 10 to establish the requirement of percutaneous tracheostomy. If clinical condition determines that the patient needs a percutaneous tracheostomy, this will be performed between days 11 and 14.
    Other Name: Prolonged endotracheal intubation
  • Experimental: Early percutaneous tracheostomy
    Intervention: Procedure: Percutaneous tracheostomy
  • Active Comparator: Prolonged translaryngeal intubation
    Intervention: Procedure: Prolonged translaryngeal intubation
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
Unknown status
June 2012
April 2012   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Written informed consent has been obtained for the procedure
  • Patients whose need of mechanical ventilation is estimated in ≥ 7 days and require a percutaneous tracheostomy

Exclusion Criteria:

  • Patients younger than 18 years old
  • Patients with neurologic pathology
  • Patients with dysphagia history
  • Patients whose MV duration is estimated in < 7 days
  • Patients with airway obstruction requiring an emergency tracheostomy
  • Patients already having a tracheostomy in situ
  • Pregnancy
  • Patients who have already been enrolled on another trial
  • Patients with absolute contraindication to perform a percutaneous tracheostomy
  • Patients with high risk of dying, life expectancy of < 48 hours
  • Patients in whom limitation of therapy has been decided
  • Family rejection to participate in the study
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
Contact information is only displayed when the study is recruiting subjects
FONIS SA10I20012
Not Provided
Not Provided
Carlos Romero. Principal Investigator, Universidad de Chile
University of Chile
Comisión Nacional de Investigación Científica y Tecnológica
Principal Investigator: Carlos M Romero, MD University of Chile
University of Chile
December 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP